Swiss pharmaceutical giant Roche Holding AG reported Wednesday 5 percent increase in the first-quarter sales at constant exchange rates, mainly driven by strong sales growth in both operating divisions. Demand for oncology and immunology medicines drove growth in pharmaceuticals, and immunodiagnostics products drove growth in diagnostics.